News

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...
Obesity is a global pandemic. According to the World Health Organization (WHO), adult obesity in the world more than doubled ...
Trump administration has rejected Biden proposal to expand coverage Medicare currently covers Ozempic, Mounjaro solely for diabetes Wegovy, Zepbound not covered for weight loss Trump ...
Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...
NAUSEA, constipation, breathing problems, racing heart… the list of Ozempic side effects appears to be growing by the day.
"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss.
As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...
A 2024 study suggests you may get better weight loss results with tirzepatide, the active ingredient in Zepbound and Mounjaro, than with semaglutide, the active ingredient in Ozempic and Wegovy.
In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...
Ozempic is what's known as a GLP-1, a drug class that's prescribed to manage Type 2 diabetes and is effective for weight loss.
Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...